Sign up for free newsletter

 

Dollars

SPDR S&P Biotech ETF receives settlement payment


State Street Global Advisors’ SPDR S&P Biotech ETF has received a payment as an authorised claimant from a class action settlement related to Dendreon Corp.

The total amount payable to the fund is USD233,312.
 
When the fund calculates its net asset value (NAV) per share on 19 August it is estimated that the fund’s NAV will be impacted by USD0.0311 for each of the existing 7,500,000 shares.

Furtherreading
from ETF Express

VanEck launches green bond ETF

Tue 07/03/2017 - 10:03

from our other sites
events
5 days 23 hours from now - Hong Kong
6 days 23 hours from now - Toronto
1 week 1 day from now - Shanghai
training
Sun, 09/04/2017   - Dubai
Mon, 15/05/2017   - London
Mon, 15/05/2017   - London
specialreports
other gfm publications